Skip to main content

Psychedelics in Psychiatry

  • 1st Edition, Volume 181 - June 20, 2025
  • Latest edition
  • Editors: David J. Nutt, Hannah Thurgur
  • Language: English

Psychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presen… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

Psychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this new volume include History of psychedelic drug science and molecular pharmacology, Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents, Anti-inflammatory activity, Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents, Clinical pharmacology, Human neuroimaging fMRI, and more.

Other chapters in this new release include Effects of psychedelics on human oscillatory brain activity, Molecular neuroimaging of psychedelic drug effects, Neurobiology of sub-psychedelic doses, Depression and related disorders, Addictions, Trauma disorders, Neurological disorders, and Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy.

Key features

  • Provides the authority and expertise of leading contributors from an international board of authors
  • Presents the latest release in the International Review on Neurobiology series
  • Includes updated information on Psychedelics in Psychiatry

Readership

Undergraduates, graduates, academics, and researchers in the field of Neurology

Table of contents

Section 1

1. History of psychedelic drug science and molecular pharmacology

2. Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents

3. Anti-inflammatory activity

4. Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents

5. Clinical pharmacology

6. Human neuroimaging fMRI

7. Effects of psychedelics on human oscillatory brain activity

8. Molecular neuroimaging of psychedelic drug effects

9. Neurobiology of sub-psychedelic doses

Section 2

10. Depression and related disorders

11. Addictions

12. Trauma disorders

13. Neurological disorders

Section 3

14. Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy

Product details

  • Edition: 1
  • Latest edition
  • Volume: 181
  • Published: June 20, 2025
  • Language: English

About the editor

DN

David J. Nutt

Affiliations and expertise
Psychopharmacology Unit, University of Bristol, UK Professor of Psychopharmacology

View book on ScienceDirect

Read Psychedelics in Psychiatry on ScienceDirect